bathocuproine has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnham, KJ; Bush, AI; Cherny, RA; Masters, CL; Yao, S | 1 |
| Atwood, CS; Beyreuther, K; Bush, AI; Cherny, RA; Fairlie, DP; Huang, X; Legg, JT; Masters, CL; McLean, CA; Tanzi, RE | 1 |
2 other study(ies) available for bathocuproine and Alzheimer Disease
| Article | Year |
|---|---|
Characterizing bathocuproine self-association and subsequent binding to Alzheimer's disease amyloid beta-peptide by NMR.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Humans; Hydrogen; Kinetics; Magnetic Resonance Spectroscopy; Peptide Fragments; Phenanthrolines | 2004 |
Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Chelating Agents; Copper; Egtazic Acid; Ethylenediamines; Humans; Phenanthrolines; Water; Zinc | 1999 |